Stay updated on KZR-616 in PM and DM Open-label Extension Clinical Trial
Sign up to get notified when there's something new on the KZR-616 in PM and DM Open-label Extension Clinical Trial page.

Latest updates to the KZR-616 in PM and DM Open-label Extension Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedRevision label updated from v3.6.0 to v3.6.3, indicating a newer page version. This is a metadata update and does not modify the study content.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedRecruitment status changed to 'No longer looking for participants' and a new version tag 'Revision: v3.6.0' were added. The page now includes new help/navigation items (How to Read a Study Record, Common Questions, How to Join a Study) and a new heading 'Intervention/Treatment' while the old 'Intervention / Treatment' heading was removed.SummaryDifference0.4%

- Check30 days agoChange DetectedAdded a new Revision: v3.5.5 entry and removed Revision: v3.5.4 from the page's revision history, reflecting a minor metadata update to the document. This indicates a small update to the page's revision record rather than a substantive change to the content.SummaryDifference0.1%

- Check52 days agoChange DetectedThe page now shows revision v3.5.4, replacing the previous v3.5.3 to indicate a newer build in the site’s version history. This update records a minor revision without altering visible content.SummaryDifference0.1%

- Check73 days agoChange DetectedThe page footer revision label was updated from “Revision: v3.5.2” to “Revision: v3.5.3,” reflecting a minor release/update of the site presentation. No study details appear to have been altered.SummaryDifference0.1%

- Check80 days agoChange DetectedThe revision label on the page was updated to v3.5.2, replacing the previous v3.5.0 label.SummaryDifference0.1%

Stay in the know with updates to KZR-616 in PM and DM Open-label Extension Clinical Trial
Enter your email address, and we'll notify you when there's something new on the KZR-616 in PM and DM Open-label Extension Clinical Trial page.